link ae888

Biochips production receives State incentives

A health project on producing genetic biochips being implemented at the Saigon High-Tech Park is now included in a national plan on high-tech industries development through 2020, as approved by the PM
Biochips production receives State incentives ảnh 1(Photo: VNA)

Ho Chi Minh City (VNA) - A health project on producing genetic biochips being implemented at the Saigon High-Tech Park (SHTP) in Ho Chi Minh City is now included in a national plan on high-tech industries development through 2020, as approved by the Prime Minister.

Therefore, it will be eligible for preferential policies and treatments regulated at Resolution 2457/QD-TTg. These incentives include research and production support, particularly in infrastructure construction and manpower training.

Licenced in April 2015, the project is expected to turn out 360,000 biochips annually.

The products will be used to treat heart diseases and to detect tuberculosis, cancer, and congenital deaf, among others. Many of them have been applied in medical units nationwide.

As of September 2015, the SHTP is home to 82 valid investment projects with a total registered capital of 4.38 billion USD.

SHTP's export turnover rose from 5 percent of the city's total exports in 2011 to 14𝓀.19 percent in 2014 and 18 percent in the first nine months of this year.-VNA

VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

Forum spotligh🍌ts AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

Vietnam, France collaborate in♑ vaccine production technology transfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
{dagathomo tructiep hôm nay}|{link link link ae888}|{dá gà thomo}|{trực tiếp đá gà thomo hom nay}|{sbobet asian handicap}|